Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c163 |
|---|---|
| Identifier | NCT07059130 |
| Trial Title | Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease (CD)|Crohns Disease|Ulcerative Colitis (UC) |
| Interventions | BIOLOGICAL: Mirikizumab |
Participant Information
| Sponsor | Rubix LS |
|---|---|
| City | Lawrence |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-07-16 |
|---|---|
| Primary Completion Date | 2026-01-01 |
| Completion Date | 2026-02-28 |